Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls ; day:19 ; month:3 ; year:2024 ; pages:1-17
Molecular psychiatry ; (19.3.2024), 1-17
- Urheber
-
Bavato, Francesco
Barro, Christian
Schnider, Laura K.
Simrén, Joel
Zetterberg, Henrik
Seifritz, Erich
Quednow, Boris B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02524-6
- URN
-
urn:nbn:de:101:1-2405211146457.348350459485
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bavato, Francesco
- Barro, Christian
- Schnider, Laura K.
- Simrén, Joel
- Zetterberg, Henrik
- Seifritz, Erich
- Quednow, Boris B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilaments in progressive multiple sclerosis: a systematic review
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Blood-based molecular biomarkers for Alzheimer’s disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilaments in progressive multiple sclerosis: a systematic review